NasdaqCM - Delayed Quote USD

AVITA Medical, Inc. (RCEL)

8.72

+0.37

(+4.43%)

At close: May 14 at 4:00 PM EDT

8.49

-0.23

(-2.64%)

After hours: May 14 at 6:23 PM EDT

Key Events

Loading Chart for RCEL

9/21 12:03 PM

DELL

Previous Close 8.35
Open 7.94
Bid 8.66 x 100
Ask 8.77 x 100
Day's Range 7.51 - 8.83
52 Week Range 7.51 - 21.70
Volume 508,060
Avg. Volume 256,603
Market Cap (intraday) 224.973M
Beta (5Y Monthly) --
PE Ratio (TTM) --
EPS (TTM) -1.40
Earnings Date Aug 8, 2024 - Aug 12, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 23.40

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

www.avitamedical.com

207

Full Time Employees

December 31

Fiscal Year Ends

Sector

Medical Devices

Industry

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RCEL

36.44%

S&P 500

10.00%

1-Year Return

RCEL

27.99%

S&P 500

27.22%

3-Year Return

RCEL

56.20%

S&P 500

27.58%

5-Year Return

RCEL

69.88%

S&P 500

86.59%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

AVITA Medical, Inc.

8.72

+4.43%

Mkt Cap 224.973M

Industry Medical Devices

Hyperfine, Inc.

0.8799

+10.14%

Mkt Cap 57.527M

Industry Medical Devices

Delcath Systems, Inc.

7.07

+30.93%

Mkt Cap 196.436M

Industry Medical Devices

5.82

+0.34%

Mkt Cap 143.494M

Industry Medical Devices

2.2200

+14.43%

Mkt Cap 20.938M

Industry Medical Devices

NeuroPace, Inc.

8.51

-0.12%

Mkt Cap 245.104M

Industry Medical Devices

14.67

-2.20%

Mkt Cap 618.072M

Industry Medical Devices

PolyNovo Limited

2.1600

-3.57%

Mkt Cap AUD 1.491B

Industry Medical Devices

Profound Medical Corp.

8.21

+7.32%

Mkt Cap 200.561M

Industry Medical Devices

Cytosorbents Corporation

0.8316

-0.38%

Mkt Cap 45.335M

Industry Medical Devices

Orthofix Medical Inc.

15.13

+0.33%

Mkt Cap 567.818M

Industry Medical Devices

Valuation Measures

As of 5/13/2024

Market Cap

215.43M
Enterprise Value

168.78M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

4.22
Price/Book (mrq)

4.39
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

-88.41%
Return on Assets (ttm)

-32.80%
Return on Equity (ttm)

-81.39%
Revenue (ttm)

50.7M
Net Income Avi to Common (ttm)

-44.82M
Diluted EPS (ttm)

-1.40

Balance Sheet and Cash Flow

Total Cash (mrq)

68.18M
Total Debt/Equity (mrq)

134.59%
Levered Free Cash Flow (ttm)

--

RCEL does not have Company Insights

TELA TELA Bio, Inc.

5.82

+0.34%

REPL Replimune Group, Inc.

6.71

+1.82%

SIBN SI-BONE, Inc.

14.67

-2.20%

ORIC ORIC Pharmaceuticals, Inc.

9.09

+1.34%

TCMD Tactile Systems Technology, Inc.

13.63

-1.45%

PHAT Phathom Pharmaceuticals, Inc.

10.39

+7.45%

RLMD Relmada Therapeutics, Inc.

3.6400

+3.12%

MIRM Mirum Pharmaceuticals, Inc.

24.80

+0.08%

RAPT RAPT Therapeutics, Inc.

4.0000

-9.09%

CABA Cabaletta Bio, Inc.

11.23

-0.27%

MORF Morphic Holding, Inc.

28.36

-1.12%

ETNB 89bio, Inc.

9.09

+4.48%

PROF Profound Medical Corp.

8.21

+7.32%

YMAB Y-mAbs Therapeutics, Inc.

11.82

-3.04%

STRO Sutro Biopharma, Inc.

4.3400

+2.60%

SRRK Scholar Rock Holding Corporation

14.01

+2.71%